EMA committee recommends approval of 10 mg rivaroxaban for extended prevention of VTE Sep. 19, 2017 No Comments
Catalyst Biosciences reports initial data from phase I/II study of CB-2679d in hemophilia B Sep. 7, 2017 No Comments
Bioverativ and Bicycle form research collaboration in hemophilia and sickle cell disease Sep. 6, 2017 No Comments
FDA gives rare pediatric disease designation to Global Blood Therapeutics' GBT-440 Sep. 6, 2017 No Comments
RSS